zhou jian

Prof. zhou jian

Fujian Institute of Microbiology, Fuzhou, Fujian, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
WZWei Zhao
Wei Zhao
Hong JiangHong Jiang
Hong Jiang
XLXiaowan LIU
Xiaowan LIU
zhou jianzhou jian
zhou jian
Bin WuBin Wu
Bin Wu
Over the past few decades (covering 1972 to 2022), astounding progress has been made in the elucidation of structures, bioactivities and biosynthesis of polyene macrolactams (PMLs), but they have only been partially summarized. PMLs possess a wide range of biological activities, particularly distinctive fungal inhibitory abilities, which render them a promising drug candidate. Moreover, the unique biosynthetic pathways including β-amino acid initiation and pericyclic reactions were presented in PMLs, leading to more attention from inside and outside the natural products community. According to current summation, in this review, the chem- and bio-diversity of PMLs from marine and terrestrial sources are considerably rich. A systematic, critical and comprehensive overview is in great need. This review described the PMLs’ general structural features, production strategies, biosynthetic pathways and the mechanisms of bioactivities. The challenges and opportunities for the research of PMLs are also discussed.

17 January 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
源袁源 袁
源 袁
LYLu Yang
Lu Yang
FZFang Zhikai
Fang Zhikai
CCCcc Ccc
Ccc Ccc
FSFei Sun
Fei Sun
zhou jianzhou jian
zhou jian
Geldanamycin, a benzoquinone ansa antibiotic, has been extensively applied in medical, agricultural, and health research areas due to its antitumor, antifungal, herbicidal, and antiradiation effects. In this study, an improvement of geldanamycin production by Streptomyces geldanamycininus FIM18-0592 was first performed by protoplasts combined with UV mutagenesis and ribosome engineering technology, respectively. The results showed that strains induced by UV mutagenesis of protoplasts were superior to protoplasts treated with erythromycin in terms of the positive variability, average relative titer, and maximum relative titer, with values of 51.95%, 99%, and 136%, respectively. A mutant strain that produced 3742 μg/mL geldanamycin was generated by protoplast UV mutagenesis, with a 36% higher yield than the initial strain. Multi-omic analysis revealed that the high-yielding geldanamycin in mutant strain 53 could upregulate GdmG and GdmX by 1.59 and 2.38 times in the ansamycin synthesis pathway, and downregulate pks12, pikAI, and pikAII by 0.25, 0.37, and 0.48 times in the fatty acid synthesis pathway, which was crucial for geldanamycin production. Our study provides a novel S. geldanamycininus geldanamycin production strategy and offers valuable insights for mutagenesis and breeding of other microorganisms.

13 October 2025 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
FSFei Sun
Fei Sun
YYYuan Yuan
Yuan Yuan
HCHaimin Chen
Haimin Chen
ZFZhikai Fang
Zhikai Fang
YSYeshi Shi
Yeshi Shi
zhou jianzhou jian
zhou jian

30 September 2026 in Chemistry & Biodiversity
Verified
Journal Article
Open access
PDF file
MCMinghong Chen
Minghong Chen
CZChengzeng Zhou
Chengzeng Zhou
RLRu Lin
Ru Lin
YYYuan Yuan
Yuan Yuan
zhou jianzhou jian
zhou jian
Verrucosispora sp. FIM06025 was an actinomycete isolated from marine sponge sample collected from the East China Sea. Three new compounds, including two rare cyclopropane‐containing compounds, verrucacrylic acids A and B ( 1 and 2 ), and a new amino acid derivative, methyl N ‐[(2 S )‐2‐methylbutanoyl]‐ D ‐tyrosinate ( 3 ), were isolated from Verrucosispora sp. FIM06025. Compounds 1–3 were structurally elucidated on the basis of extensive spectroscopic data analysis using 1D‐ and 2D‐NMR, ECD, and HRESIMS. At a concentration of 100 µM, compounds 1 and 2 exhibited inhibitory rates of 28.6% and 45.2% against T47D cells, respectively, and 30.3% and 47.1% against HL60 cells, respectively.